Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents

Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents

Purpose: Metastatic, persistent, or recurrent epithelial ovarian cancer (MPR-EOC) remains a significant threat to patient mortality despite advances in novel targeted agents. Radiation therapy (RT) is often used as a palliative option. We report outcomes of a large series of MPR-EOC patients treated...

Full description

Bibliographic Details
Main Authors: Anish A. Butala, MD, Roshal R. Patel, BA, Shwetha Manjunath, MD, Nawar A. Latif, MD, MPH, MSCE, Ashley F. Haggerty, MD, MSCE, Joshua A. Jones, MD, FAAHPM, Neil K. Taunk, MD, MSCTS
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109420303547

Internet

http://www.sciencedirect.com/science/article/pii/S2452109420303547

Similar Items